As shown in Fig. 2d, the coadministration of two drugs has a significant synergistic inhibitory effect on EGFRm tumor cells but less cytotoxicity on cells with normal EGFR or little toxic side effects on immortalized epithelial cells. The gene discussed is EGFR; the disease is neoplasm.